Literature DB >> 15956407

Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region.

Johann D D Pitout1, Daniel B Gregson, Deirdre L Church, Sameer Elsayed, Kevin B Laupland.   

Abstract

Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) typically cause nosocomial infections. Previous surveillance in the Calgary Health Region showed that Escherichia coli strains producing ESBLs were common among community patients. During the period (2000 to 2002): 23 of 157 (15%) of the strains were positive for blaCTX-M genes from the CTX-M-I group (CTX-M-1-like) and 87 of 157 (55%) of the strains were positive for blaCTX-M genes from the CTX-M-III group (CTX-M-14-like). The objective of this study was to investigate the molecular epidemiology of these strains. The beta-lactamases were characterized, and the genetic relatedness of the isolates was analyzed by digesting genomic DNA with the restriction endonuclease XbaI and by performing pulse-field gel electrophoresis (PFGE). PFGE revealed two closely related restriction patterns (clusters CTXM14A and CTXM14AR) among 67 (77%) CTX-M-14 producers. These strains from CTXM14A had nearly identical susceptibility patterns and were isolated most often from urine samples obtained at community sites during 2000 and 2001. Strains from the CTX-M-1-like and CTX-M-negative groups were unrelated to clusters CTXM14, CTXM14AR, and CTXM14NR. We conclude that clonally related strains of E. coli producing CTX-M-14 beta-lactamases were responsible for a predominantly community-wide outbreak. Further studies are warranted to investigate whether community-onset diseases caused by ESBL-producing E. coli are related to a point source or transmission within the community.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956407      PMCID: PMC1151948          DOI: 10.1128/JCM.43.6.2844-2849.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

Review 1.  Multi-resistant Gram-negative bacilli: from epidemics to endemics.

Authors:  Rafael Cantón; Teresa M Coque; Fernando Baquero
Journal:  Curr Opin Infect Dis       Date:  2003-08       Impact factor: 4.915

2.  Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.

Authors:  L B Rice; S H Willey; G A Papanicolaou; A A Medeiros; G M Eliopoulos; R C Moellering; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli.

Authors:  L Ma; Yoshikazu Ishii; Feng-Yee Chang; Keizo Yamaguchi; Monto Ho; L K Siu
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections.

Authors: 
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

6.  Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

Authors:  J Wiener; J P Quinn; P A Bradford; R V Goering; C Nathan; K Bush; R A Weinstein
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

7.  Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.

Authors:  L B Rice; E C Eckstein; J DeVente; D M Shlaes
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

8.  Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.

Authors:  C J Munday; G M Whitehead; N J Todd; M Campbell; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2004-08-04       Impact factor: 5.790

9.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

10.  Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes.

Authors:  Johann D D Pitout; Nancy D Hanson; Deirdre L Church; Kevin B Laupland
Journal:  Clin Infect Dis       Date:  2004-05-25       Impact factor: 9.079

View more
  45 in total

1.  Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region.

Authors:  Gisele Peirano; Akke K van der Bij; Daniel B Gregson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.

Authors:  A Gündoğdu; Y B Long; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-24       Impact factor: 3.267

3.  Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: association with distinct demographic groups in the community in New Zealand.

Authors:  J T Freeman; D A Williamson; H Heffernan; M Smith; J E Bower; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-23       Impact factor: 3.267

4.  Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands.

Authors:  N al Naiemi; A Bart; M D de Jong; C M Vandenbroucke-Grauls; P J G M Rietra; Y J Debets-Ossenkopp; P C Wever; L Spanjaard; A J Bos; B Duim
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Jérôme Moreau; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

6.  Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene.

Authors:  Il Kwon Bae; You-Nae Lee; Wee Gyo Lee; Sang Hee Lee; Seok Hoon Jeong
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

7.  Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels.

Authors:  James H Jorgensen; M L McElmeel; L C Fulcher; B L Zimmer
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

8.  Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.

Authors:  Priyaranjan Pattanaik; Christopher R Bethel; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Magdalena Taracila; Vernon E Anderson; Thomas R Fritsche; Ronald N Jones; Sundar Ram Reddy Pagadala; Focco van den Akker; John D Buynak; Robert A Bonomo
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

9.  Phenotypic and molecular characterization of two novel CTX-M enzymes carried by Klebsiella pneumoniae.

Authors:  Jun Cheng; Wei Gao; Jun Yin; Zhen Sun; Ying Ye; Yu-Feng Gao; Xu Li; Jia-Bin Li
Journal:  Mol Biol Rep       Date:  2009-03-18       Impact factor: 2.316

10.  Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain.

Authors:  Aránzazu Valverde; Rafael Cantón; M Pilar Garcillán-Barcia; Angela Novais; Juan Carlos Galán; Andrés Alvarado; Fernando de la Cruz; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.